Prerna Kulbhushan Chawla1, Rohan V. Lokhande2, Prasad R. Naik3, Alpa J. Dherai4, Zarir F. Udwadia5, Ashok A. Mahashur6, Rajeev Soman7, Jignesh Patel8, Tester F. Ashavaid9
(1.P.D. HINDUJA HOSPITAL & MRC, 2.P.D. Hinduja National Hospital and Medical Research Centre, 3.P.D. Hinduja National Hospital and Medical Research Centre, 4.P.D. Hinduja National Hospital and Medical Research Centre, 5.P.D. Hinduja National Hospital and Medical Research Centre, 6.P.D. Hinduja National Hospital and Medical Research Centre, 7.P.D. Hinduja National Hospital and Medical Research Centre, 8.P.D. Hinduja National Hospital and Medical Research Centre, 9.P.D. Hinduja National Hospital and Medical Research Centre)
Keywords:Rifampicin, Isoniazid, NAT2 acetylator status, Therapeutic Drug Monitoring, India
Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.